Akira Inoue, Kunihiko Kobayashi, Makoto Maemondo, Shunichi Sugawara, Satoshi Oizumi, Hiroshi Isobe, Akihiko Gemma, Masao Harada, Hirohisa Yoshizawa, Ichiro Kinoshita, Yuka Fujita, Shoji Okinaga, Haruto Hirano, Kozo Yoshimori, Toshiyuki Harada, Yasuo Saijo, Koichi Hagiwara, Satoshi Morita, Toshihiro Nukiwa, for the North-East Japan Study Group: Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002). Annals of Oncology 24(1): 54–59, 2013
Chikashi Terao, Hajime Yoshifuji, Akinori Kimura, Takayoshi Matsumura, Koichiro Ohmura, Meiko Takahashi, Masakazu Shimizu, Takahisa Kawaguchi1, Zhiyong Chen, Taeko K. Naruse, Aiko Sato-Otsubo, Yusuke Ebana, Yasuhiro Maejima7, Hideyuki Kinoshita, Kosaku Murakami, Daisuke Kawabata2, Yoko Wada, Ichiei Narita, Junichi Tazaki, Yasushi Kawaguchi, Hisashi Yamanaka, Kimiko Yurugi, Yasuo Miura, Taira Maekawa, Seishi Ogawa, Issei Komuro, Ryozo Nagai, Ryo Yamada, Yasuharu Tabara, Mitsuaki Isobe, Tsuneyo Mimori, Fumihiko Matsuda: Two Susceptibility Loci to Takayasu Arteritis Reveal a Synergistic Role of the IL12B and HLA-B Regions in a Japanese Population. American Journal of Human Genetics 93(2): 289–297, 2013
Hiroshi Saito, Hirohisa Yoshizawa, Kozo Yoshimori, Nobuyuki Katakami, Noriyuki Katsumata, Masaaki Kawahara, Kenji Eguchi: Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. Annals of Oncology 24(4): 1067–1073, 2013
Jun Koshio, Hiroshi Kagamu, Koichiro Nozaki, Yu Saida, Tomohiro Tanaka, Satoshi Shoji, Natsue Igarashi, Satoru Miura, Masaaki Okajima, Satoshi Watanabe, Hirohisa Yoshizawa, Ichiei Narita: DEAD/H (Asp–Glu–Ala–Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells. Cancer Immunol Immunother 62(10): 1619-1628, 2013
Takashi Hasegawa, Toshiyuki Koya, Takuro Sakagami, Hiroshi Kagamu, Masaaki Arakawa, Fumitake Gejyo, Ichiei Narita, Eiichi Suzuki, Niigata Asthma Treatment Study Group: The Asthma Control Test, Japanese Version (ACT-J) as a Predictor of Global Initiative for Asthma (GINA) Guideline-Defined Asthma Control: Analysis of a Questionnaire-Based Survey. Allergology International 62(3): 323-330, 2013
Satoru Miura, Satoshi Watanabe, Kazuhiro Sato, Masato Makino, Osamu Kobayashi, Hiromi Miyao, Akira Iwashima, Masaaki Okajima, Junta Tanaka, Hiroshi Tanaka, Hiroshi Kagamu, Akira Yokoyama, Ichiei Narita, Hirohisa Yoshizawa: The efficacy of triplet antiemetic therapy with 0.75 mg of palonosetron for chemotherapy-induced nausea and vomiting in lung cancer patients receiving highly emetogenic chemotherapy. Support Care Cancer 21(9): 2575–2581, 2013
Daisuke Ishikawa, Shinji Takeuchi, Takayuki Nakagawa, Takako Sano, Junya Nakade, Shigeki Nanjo, Tadaaki Yamada, Hiromichi Ebi, Lu Zhao, Kazuo Yasumoto, Takahiro Nakamura, Kunio Matsumoto, Hiroshi Kagamu, Hirohisa Yoshizawa, Seiji Yano: mTOR Inhibitors Control the Growth of EGFR Mutant Lung Cancer Even after Acquiring Resistance by HGF. PLoS One 8(5): e62104, 2013
Takako Saeki, Mitsuhiro Kawano, Ichiro Mizushima, Motohisa Yamamoto, Yoko Wada, Hitoshi Nakashima, Noriyuki Homma, Yutaka Tsubata, Hiroki Takahashi, Tomoyuki Ito, Hajime Yamazaki, Takao Saito, Ichiei Narita: The clinical course of patients with IgG4-related kidney disease. Kidney International 84(4): 826–833, 2013
Yosuke Kimura, Toshiyuki Koya, Hiroshi Kagamu, Kenjiro Shima, Hirotaka Sakamoto, Hidenori Kawakami, Yoshifumi Hoshino, Toshiki Furukawa, Takuro Sakagami, Takashi Hasegawa, Masami Narita, Eiichi Suzuki, Ichiei Narita: A single injection of a sustained-release prostacyclin analog (ONO-1301MS) suppresses airway inflammation and remodeling in a chronic house dust mite-induced asthma model. European Journal of Pharmacology 721(1-3): 80-85, 2013